There is a particular kind of dread that comes from watching a non-dilutive funding source—one you have quietly built your runway model around—start to wobble. For a significant slice of Metro Vancouver’s tech and life sciences founders, that dread arrived in early 2026, when Ottawa’s federal budget signalled a formal review of the Scientific Research and Experimental Development (SR&ED) tax credit program, specifically the refundable credit rate available to Canadian-Controlled Private Corporations (CCPCs). While the government has not yet legislated a final rate, the signal alone has prompted action.

SR&ED—often called "shred" by those who file claims—is Canada’s largest federal tax incentive for business R&D. For CCPCs, the refundable portion of the credit has historically allowed companies with little or no taxable income to receive cash back from the CRA, rather than a simple paper deduction. That distinction is the difference between a program that matters and one that only matters to profitable firms. British Columbia consistently ranks among the top three provinces by SR&ED claim volume, with Metro Vancouver’s tech cluster driving the bulk of that activity.

The proposed changes remain under consultation. However, in a sector where runway is measured in months and hiring decisions are made quarters in advance, the uncertainty functions as a starting gun.

The most common response among founders is claim acceleration—pulling eligible R&D expenditures into the current fiscal year before any rate change takes effect. If a company plans to run a qualifying experiment over 18 months, there is nothing wrong with front-loading the expenditure into a fiscal year that still benefits from the current refundable rate. The CRA’s eligibility guidelines require that work be genuinely experimental, but companies can sequence real work strategically.

A second, more complex response involves subsidiary restructuring. Some founders are examining whether shifting eligible R&D activity into a separate CCPC—one optimized for SR&ED eligibility—makes sense given their current corporate structure. While tax advisory firms like KPMG and PwC are fielding a surge in SR&ED-related mandates, this strategy can preserve meaningful cash over a multi-year horizon if the rate change is significant.

The current enhanced refundable rate for CCPCs sits at 35 per cent on the first $3 million of qualified expenditures, with a basic rate of 15 per cent above that threshold. A reduction of even five percentage points on the enhanced rate would translate to a $150,000 swing on a $3-million R&D spend. Scale that across BC’s SR&ED claim base and the result is a material reallocation of capital out of the startup ecosystem.

The BC Tech Association has flagged to Ottawa that Metro Vancouver’s startup density makes the province disproportionately exposed to any rate reduction. The Canadian Venture Capital and Private Equity Association has argued that SR&ED functions as a de facto co-investor in early-stage Canadian tech, and that reducing it will accelerate the tendency of BC founders to relocate R&D work to US subsidiaries.

SR&ED remains one of the few structural advantages Canada offers a founder facing pressure to Delaware-incorporate and hire in the US. Weaken SR&ED and you weaken one of the few counterweights to the gravitational pull of US capital markets.

The optimistic view is that Ottawa’s review may preserve the CCPC refundable rate while tightening eligibility criteria or reducing the basic rate for larger corporations. The pessimistic view is that the government, facing fiscal pressure, trims the headline rate across the board. Smart founders are acting as though the change is coming, structuring their claims and corporate architecture accordingly.

What to watch:

• The federal government's formal legislative response to the SR&ED review consultation, which may be addressed in the fall 2026 fiscal update or a subsequent budget implementation bill.
• CRA’s updated SR&ED program statistics for fiscal 2024–25, which will establish the baseline BC claim volume against which any rate change should be measured.
• Whether the BC Tech Association’s lobbying effort produces a provincial top-up mechanism to partially offset a federal rate reduction.
• Hiring data at Metro Vancouver’s mid-stage tech companies in Q3 and Q4 2026—a key indicator of whether SR&ED uncertainty is affecting R&D headcount.